Another home-run for lung cancer at #ASCO24 : the #ADRIATIC trial in limited-stage SCLC.

#Durvalumab as consolidation treatment significantly prolongs PFS (HR 0.76, 16.6 vs 9.2 mo.) and OS (HR 0.73, 55.9 vs 33.4 mo.) compared to placebo!

ASCO OncoAlert

Practice-changing results with #osimertinib in unresectable locally advanced EGFRm NSCLC after definitive CRT!! The #LAURA trial

Osi vs. Placebo: mPFS 39.1 vs. 5.6 mo. (HR 0.16)

Congratulations to Suresh S. Ramalingam, MD, FASCO and investigators! ASCO #ASCO24

‼️ The first #neoadjuvant checkpoint inhibitor phase 3 trial in melanoma! #NADINA ‼️

Neoadj. nivo-ipi results in better EFS vs. SOC adj. (HR 0.32, p<0.0001) at 12 months regardless of BRAF status.

#ASCO24 ASCO OncoAlert

Our Dana-Farber Lank Center for Genitourinary Oncology star Emre Yekedüz taking on unclassified #RCC genomic features #ASCO24 ASCO

🚨The #ESOPEC trial at the #ASCO24 plenary session:

➡️ Perioperative chemo shows better survival than neoadj. chemoradio (OS HR 0.7, 95% CI 0.53–0.92) in the treatment of pts w/ #esophageal adenocarcinoma!

OncoAlert ASCO

2 Dana-Farber Lank Center for Genitourinary Oncology studs in Karl Semaan, MD, MSc and Talal El Zarif, MD (now PGY1 Yale Internal Medicine) presenting data on therapies post adjuvant IO in RCC. Paper may also be coming soon !

ASCO #ASCO24 OncoAlert

Our super star Bradley McGregor combining 3 drugs: 2 ADCs+IO in bladder cancer—trial open Dana-Farber Lank Center for Genitourinary Oncology #ASCO24 ASCO

An incredible overview by Toni Choueiri, MD of the challenges that IMGs face, but also all the various initiatives that are helping overcome them! This includes primary data by Ayesha Butt, MD Coral Olazagasti, MD Arya Roy

Thanks to ASCO for supporting these efforts and to Dr. Choueiri for

Some numbers “Hope do we create a diverse task force in Oncology in 🇺🇸 “

#ASCO24

❗️Make sure not to miss this education session and my talk on “Recognizing, Celebrating, and Supporting #IMGs in Oncology” at #ASCO24 ❗️

Today, 10-10:15 AM
Room S102

ASCO OncoAlert IMG Oncologists

Super star in the making! Hard work, charisma and brilliance. Soon to be ready for IM Residency! Dana-Farber Lank Center for Genitourinary Oncology ASCO IMG Oncologists Marc Machaalani #ASCO24

❗️Make sure not to miss this education session and my talk on “Recognizing, Celebrating, and Supporting #IMGs in Oncology” at #ASCO24 ❗️

Today, 10-10:15 AM
Room S102

ASCO OncoAlert IMG Oncologists

Narratives in Oncology Through the Years ascopost.com/issues/june-3-… #NarrativesInOncology

SPECIAL REPORT: American Cancer Society, ASCO combine online patient information services. Conversation with Karen Knudsen, MBA PhD & Clifford Hudis
cancerletter.com/conversation-w…

More than 44,000 people @asco, but the GU people seem to find each other right away. I love my field!
Toni Choueiri, MD Phil Kantoff Lorelei Mucci Michael Morris
#ASCO24

👏👏 don’t missed the next #ASCO24 championship!! Next monday 👇👇 we expect more than 10,000 supporters attending!!
🇦🇷🇧🇷🇪🇸🇺🇸🇫🇷🇨🇴🇵🇪🇺🇳 ASCO ASCOPost OncoAlert Toni Choueiri, MD FabriceAndre ESMO - Eur. Oncology UroTarget UroToday.com Neeraj Agarwal, MD, FASCO

And it is 2-0 for Real Madrid C.F. !

#ASCO24

Our society ASCO knows #Wellness and practice #Wellness —therefore the live UEFA Champions League Final between Borussia Dortmund vs Real Madrid C.F. !!! Huge Audience !!! #ASCO24

Game is starting and the Borussia Dortmund and Real Madrid C.F. fans are flocking to Hall D2 Garden. Thank you ASCO and Mandy Davis Aitken for making this happen ! #ASCO24 UEFA Champions League